GR3019019T3 - Chalcone derivatives, process for their preparation and pharmaceutical compositions containing them - Google Patents
Chalcone derivatives, process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- GR3019019T3 GR3019019T3 GR960400420T GR960400420T GR3019019T3 GR 3019019 T3 GR3019019 T3 GR 3019019T3 GR 960400420 T GR960400420 T GR 960400420T GR 960400420 T GR960400420 T GR 960400420T GR 3019019 T3 GR3019019 T3 GR 3019019T3
- Authority
- GR
- Greece
- Prior art keywords
- group
- hydrogen atom
- cirf
- lower alkyl
- case
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/60—Naphthoxazoles; Hydrogenated naphthoxazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR909007813A FR2663633B1 (fr) | 1990-06-22 | 1990-06-22 | Nouvelles chalcones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3019019T3 true GR3019019T3 (en) | 1996-05-31 |
Family
ID=9397889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR960400420T GR3019019T3 (en) | 1990-06-22 | 1996-02-20 | Chalcone derivatives, process for their preparation and pharmaceutical compositions containing them |
Country Status (16)
Country | Link |
---|---|
US (1) | US5179091A (el) |
EP (1) | EP0463945B1 (el) |
JP (1) | JPH0730054B2 (el) |
AT (1) | ATE132144T1 (el) |
AU (1) | AU631743B2 (el) |
CA (1) | CA2045256A1 (el) |
DE (1) | DE69115768T2 (el) |
DK (1) | DK0463945T3 (el) |
ES (1) | ES2084129T3 (el) |
FR (1) | FR2663633B1 (el) |
GR (1) | GR3019019T3 (el) |
IE (1) | IE912145A1 (el) |
NZ (1) | NZ238647A (el) |
OA (1) | OA09504A (el) |
PT (1) | PT98068A (el) |
ZA (1) | ZA914802B (el) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2084997A1 (en) * | 1991-04-10 | 1992-10-11 | Koji Kobayashi | Oxazinone derivative |
US6140309A (en) * | 1996-03-12 | 2000-10-31 | University Of South Florida | Vasoactive effects and free radical generation by β-amyloid peptides |
US8039026B1 (en) * | 1997-07-28 | 2011-10-18 | Johnson & Johnson Consumer Companies, Inc | Methods for treating skin pigmentation |
CN1188107C (zh) | 1998-03-16 | 2005-02-09 | 宝洁公司 | 调节皮肤外观的组合物 |
AU3002299A (en) * | 1998-03-16 | 1999-10-11 | Procter & Gamble Company, The | Methods for regulating skin appearance |
US6750229B2 (en) | 1998-07-06 | 2004-06-15 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin pigmentation |
US8106094B2 (en) * | 1998-07-06 | 2012-01-31 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for treating skin conditions |
US8093293B2 (en) * | 1998-07-06 | 2012-01-10 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin conditions |
US20020197244A1 (en) * | 1998-12-07 | 2002-12-26 | Miri Seiberg | Compositions and methods for regulating phagocytosis and ICAM-1 expression |
US7985404B1 (en) | 1999-07-27 | 2011-07-26 | Johnson & Johnson Consumer Companies, Inc. | Reducing hair growth, hair follicle and hair shaft size and hair pigmentation |
US7309688B2 (en) * | 2000-10-27 | 2007-12-18 | Johnson & Johnson Consumer Companies | Topical anti-cancer compositions and methods of use thereof |
GB0004686D0 (en) * | 2000-02-28 | 2000-04-19 | Aventis Pharma Ltd | Chemical compounds |
US20040192669A1 (en) * | 2000-04-13 | 2004-09-30 | Rosenfeld Mark J. | Novel compounds for use in weight loss and appetite suppression in humans |
US7794761B2 (en) * | 2000-04-13 | 2010-09-14 | Seroctin Research & Technology, Inc. | Methods for inducing anti-anxiety and calming effects in animals and humans |
US8431550B2 (en) * | 2000-10-27 | 2013-04-30 | Johnson & Johnson Consumer Companies, Inc. | Topical anti-cancer compositions and methods of use thereof |
US7192615B2 (en) * | 2001-02-28 | 2007-03-20 | J&J Consumer Companies, Inc. | Compositions containing legume products |
US6555143B2 (en) | 2001-02-28 | 2003-04-29 | Johnson & Johnson Consumer Products, Inc. | Legume products |
MXPA04005864A (es) * | 2001-12-19 | 2004-10-29 | Atherogenics Inc | Derivados de charcona y su uso para tratar enfermedades. |
US20030224075A1 (en) * | 2002-02-21 | 2003-12-04 | Jue-Chen Liu | Soy composition for balancing combination skin |
US20050004561A1 (en) * | 2003-07-01 | 2005-01-06 | Lynn Halas | Method for removing hair |
EP1677748A1 (en) * | 2003-10-29 | 2006-07-12 | Johnson & Johnson Consumer France SAS | Compositions comprising soy products and dioic acids |
US7524877B2 (en) | 2003-11-20 | 2009-04-28 | Seroctin Research & Technology, Inc. | Compounds for use in weight loss and appetite suppression in humans |
US20080008818A1 (en) * | 2006-06-23 | 2008-01-10 | Miri Seiberg | Partially denatured whole soybean extracts and methods of use thereof |
US20080089960A1 (en) * | 2006-10-16 | 2008-04-17 | Miri Seiberg | Use of Legume Products for the Treatment and Prevention of Radiotherapy-Induced Skin Damage |
CN103360338B (zh) * | 2013-07-30 | 2015-04-01 | 中国科学院新疆理化技术研究所 | 一种查尔酮苯并噻唑酰胺类衍生物的制备方法和用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2244506B1 (el) * | 1973-06-26 | 1977-02-25 | Inst Nat Sante Rech Med | |
FR2244507A1 (en) * | 1973-06-26 | 1975-04-18 | Inst Nat Sante Rech Med | Chalcones and analogues - analgesics having low toxicity |
FR2588868B1 (fr) * | 1985-10-21 | 1988-11-10 | Negma Laboratoires | Acyl-7 benzoxazinones et leurs derives, procede pour les obtenir et compositions pharmaceutiques les contenant |
FR2646350B1 (fr) * | 1989-04-28 | 1991-06-28 | Adir | Nouveaux derives benzothiazolinoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
1990
- 1990-06-22 FR FR909007813A patent/FR2663633B1/fr not_active Expired - Fee Related
-
1991
- 1991-06-03 US US07/709,613 patent/US5179091A/en not_active Expired - Fee Related
- 1991-06-21 AU AU79172/91A patent/AU631743B2/en not_active Ceased
- 1991-06-21 DK DK91401679.5T patent/DK0463945T3/da active
- 1991-06-21 ZA ZA914802A patent/ZA914802B/xx unknown
- 1991-06-21 IE IE214591A patent/IE912145A1/en unknown
- 1991-06-21 OA OA60028A patent/OA09504A/xx unknown
- 1991-06-21 PT PT98068A patent/PT98068A/pt not_active Application Discontinuation
- 1991-06-21 AT AT91401679T patent/ATE132144T1/de not_active IP Right Cessation
- 1991-06-21 DE DE69115768T patent/DE69115768T2/de not_active Expired - Fee Related
- 1991-06-21 CA CA002045256A patent/CA2045256A1/fr not_active Abandoned
- 1991-06-21 EP EP91401679A patent/EP0463945B1/fr not_active Expired - Lifetime
- 1991-06-21 ES ES91401679T patent/ES2084129T3/es not_active Expired - Lifetime
- 1991-06-21 NZ NZ238647A patent/NZ238647A/xx unknown
- 1991-06-24 JP JP3151498A patent/JPH0730054B2/ja not_active Expired - Fee Related
-
1996
- 1996-02-20 GR GR960400420T patent/GR3019019T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
ES2084129T3 (es) | 1996-05-01 |
EP0463945B1 (fr) | 1995-12-27 |
DE69115768T2 (de) | 1996-08-08 |
ZA914802B (en) | 1992-04-29 |
FR2663633B1 (fr) | 1994-06-17 |
IE912145A1 (en) | 1992-01-01 |
OA09504A (fr) | 1992-11-15 |
DK0463945T3 (da) | 1996-04-29 |
ATE132144T1 (de) | 1996-01-15 |
PT98068A (pt) | 1992-03-31 |
JPH0730054B2 (ja) | 1995-04-05 |
NZ238647A (en) | 1992-08-26 |
EP0463945A1 (fr) | 1992-01-02 |
AU7917291A (en) | 1992-01-02 |
US5179091A (en) | 1993-01-12 |
CA2045256A1 (fr) | 1991-12-23 |
DE69115768D1 (de) | 1996-02-08 |
FR2663633A1 (fr) | 1991-12-27 |
AU631743B2 (en) | 1992-12-03 |
JPH04230273A (ja) | 1992-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3019019T3 (en) | Chalcone derivatives, process for their preparation and pharmaceutical compositions containing them | |
DE58908652D1 (de) | Aminoalkylindole, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate. | |
ES8301927A1 (es) | Procedimiento de preparacion de acidos azabiciclohexano car-boxilicos y de sus sales | |
AU589795B2 (en) | New 5-alkoxy-2,4-diamino-alkyl benzols, and hair tinting means using them | |
NZ218243A (en) | B-carboline derivatives and pharmaceutical compositions | |
DE3170937D1 (en) | 2-(1,4-benzodioxan-2-ylalkyl) imidazoles, their preparation and pharmaceutical compositions containing them | |
HK56597A (en) | 3-aminochromane derivatives procedure for their preparation and pharmaceutical compositions containing them | |
IL75987A0 (en) | 1,6-naphthyridine derivatives,their preparation and pharmaceutical compositions containing them | |
ES8200648A2 (es) | Procedimiento de preparacion de compuestos opacificantes para radiografia y similares | |
IL87796A0 (en) | Substituted 3-aminosydnonimines,their preparation and pharmaceutical compositions containing them | |
ATE25523T1 (de) | Bicyclische phenolether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel. | |
GR3003472T3 (en) | 1-benzoyl-2-oxo-5-alkoxy-pyrrolidine derivatives, their preparation, their use and preparations containing them | |
ATE19879T1 (de) | Furyloxazolylessigsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
SE8405338A (sv) | (1,3)oxazino (4,3-a) isokinolinderivat, forfarande for deras framstellning och farmaceutiska kompositioner innehallande dem | |
ES2009283A6 (es) | Procedimiento para preparar nuevos aminoacilatos de glicerol-acetal. | |
ATE4384T1 (de) | Benzothiopyrano(2,3-c)pyridine und ihre saeureadditions-salze, ihre herstellung, ihre verwendung als arzneimittel und diese verbindungen enthaltende zusammensetzungen. | |
EP0273357A3 (en) | Fluorine-containing macrolide compounds, pharmaceutical compositions comprising the same and their use for the manufacture of medicaments | |
GB2022583A (en) | New ionic polyiodo benzene derivatives useful as X-ray contrast media | |
ES2068685T3 (es) | Procedimiento de preparacion de nuevos derivados de 1,5-diin-cicloalquenos. |